Press Releases

Amniox Medical Announces Results of Pilot Study using CLARIX® FLO for Relief of Moderate to Severe Pain Associated with Knee Osteoarthritis

Miami, FL –  January 15, 2020 – Amniox Medical, Inc. (Amniox), a TissueTech, Inc. company and pioneer in the clinical application of human birth tissue-based products, announced today the results from a single-center, prospective, investigator-initiated pilot study titled “Injectable Amniotic Membrane/Umbilical Cord Particulate for Knee Osteoarthritis.” The study was conducted on 20 patients ranging from […]

Clinical Results of Using Amniotic Membrane-Umbilical Cord Graft for Reducing Glaucoma Shunt Tube Exposure Published in Ophthalmology Glaucoma Journal

Bio-Tissue

Miami, FL – December 10, 2019 – Bio-Tissue, Inc., a TissueTech, Inc. company and leader in the clinical application of amniotic membrane and umbilical cord birth tissue products for unmet patient needs, announced today that the results from a clinical study on the use of amniotic membrane – umbilical cord grafts have been published in Ophthalmology Glaucoma, […]

TissueTech Receives 2019 Customer Digital Transformation Award

Miami, Fla. – December 4, 2019 – TissueTech, Inc., a pioneer in the development and clinical application of regenerative human birth tissue products marketed through its subsidiaries Bio-Tissue, Inc. and Amniox Medical, Inc., was awarded the 2019 Customer Digital Transformation Award by Medidata on November 13, 2019 at Medidata NEXT NYC, the premier conference dedicated to the digital transformation of life sciences. This award recognizes TissueTech’s successful migration to Medidata’s unified data platform and the resultant effectiveness the company has achieved in addressing the complexity of clinical trials and associated data handling.

TissueTech Strengthens Senior Management Team with the Appointment of Vice President of Reimbursement and Government Affairs

Miami, Fla. – December 4, 2019 – TissueTech, Inc., a pioneer in the development and clinical application of regenerative human birth tissue products marketed through its subsidiaries Bio-Tissue, Inc. and Amniox Medical, Inc., announced today the appointment of Timothy Hunter to the position of Vice President, Reimbursement and Government Affairs to oversee enterprise-wide third-party payor and reimbursement activities.    

TissueTech Announces Appointment of New Chief Commercial Officer

Miami, Fla. – November 18, 2019 – TissueTech, Inc., a pioneer in the development and clinical application of regenerative human birth tissue products marketed through its subsidiaries Bio-Tissue, Inc. and Amniox Medical, Inc., announced this week the appointment of Tom Williamson to the position of Chief Commercial Officer (CCO) to support the continued strategic expansion of its marketing, sales and commercial operations.  

Bio-Tissue Launches Website to Educate on Long-Lasting Solution for Mechanical Dry Eye (MDE), aka Conjunctivochalasis (CCh)

Miami, FL – November 12, 2019 – Bio-Tissue, Inc., a TissueTech, Inc. company and leader in the clinical application of amniotic membrane and umbilical cord-based products for unmet patient needs, announced today the launch of an educational website, www.DiscoverMDE.com , on Mechanical Dry Eye, MDE, also sometimes referred to as Conjunctivochalasis (CCh). The website features educational information, videos, testimonials and other resources for both patients and health care providers.

Bio-Tissue Founder, Pioneer in Ocular Use of Amniotic Membrane Mentors Minority Students During 2019 American Academy of Ophthalmology Meeting

Miami, FL – November 4, 2019 – Scheffer C.G. Tseng, MD, PhD, Chief Technology Officer and co-founder of Bio-Tissue, Inc., a TissueTech company, shared insights with underrepresented undergraduates and medical students about the rewards and opportunities of studying ophthalmology during their residencies at this year’s Minority Ophthalmology Mentoring Program on October 13, 2019 at the […]

Amniox Medical Announces Publication of Phase 2 Clinical Trial Results Utilizing NEOX® CORD 1K (Trial Code Name: TTAX01) in Wound Repair and Regeneration

Miami, FL – October 10, 2019 – Miami, FL – October 10, 2019 – Amniox® Medical, Inc. (Amniox), a TissueTechTM, Inc. company and leader in the clinical application of amniotic membrane and umbilical cord-based products, announced today the publication in Wound Repair and Regeneration of results from the completed Phase 2 pilot trial titled “Phase […]

TissueTech Names New Vice President to Lead Human Resources Operations and Process Improvement Initiatives

Miami, FL – October 2, 2019 – TissueTech,TM Inc., a pioneer and market leader in the development and clinical application of human birth tissue products, today announced the appointment of Kim Tripodo to the role of Vice President of Human Resources. In this role, Ms. Tripodo will be responsible for all aspects of human resource […]

TissueTech Names New Vice President to Oversee Scale Up of Product Lifecycle Management and Technology Transfer Activities

Miami, FL – September 23, 2019 – TissueTechTM, Inc., a pioneer in the development and clinical application of regenerative human birth tissue products, today announced the appointment of Jerry Chang, PhD to the position of Vice President of Product Development. In this new role, Dr. Chang will have oversight for ensuring the efficiency and integrity […]

popup close button